查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1924734

蛋白质表现和生产服务市场按表达系统、蛋白质类型、应用和最终用户划分 - 全球预测（2026-2032 年）

Protein Expression & Production Service Market by Expression System, Protein Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025年蛋白质表现和生产服务市值为8.546亿美元，预计到2026年将成长至9.3422亿美元，预计到2032年将达到16.7804亿美元，复合年增长率为10.11%。

主要市场统计数据
基准年 2025 8.546亿美元
预计年份：2026年 9.3422亿美元
预测年份：2032年 1,678,040,000 美元
复合年增长率 (%) 10.11%

从策略观点来看，蛋白质表现和生产服务被视为转化科学、商业生物製剂和诊断创新领域的关键平台技术。

蛋白质表现和生产技术在治疗药物研发、诊断技术进步和工业生物技术创新中发挥核心作用。本报告首先着重阐述蛋白质表现技术作为现代生命科学工作流程基础的重要性，涵盖从探索性研究到规模化生产的各个环节。报告着重强调了技术选择（例如表达系统的选择和平台自动化程度）如何影响下游工艺流程的时间表、可重复性和监管合规性。

技术和营运方面的转折点正在汇合，推动了表达式平台吞吐量的加速提升、模组化服务模式的建构以及以品质主导的整合。

蛋白质表现和生产领域正经历一系列变革，重塑其技术、营运和商业性竞争优势。无细胞系统的进步以及哺乳动物和酵母平台的改进提高了重现性和速度，而自动化平台的日益普及则缩短了实验週期并提高了通量。此外，高通量筛检和机器人纯化流程的整合正在改变外包与内部能力开发的标准，使得药物发现工作流程能够在减少人工干预的情况下实现规模化。

对 2025 年关税对蛋白质表现和生产服务的采购、供应链韧性和筹资策略的影响全面评估。

2025年生效的关税调整和贸易措施为依赖全球供应链获取蛋白质表现和生产相关试剂、耗材和专用设备的企业带来了新的挑战。这些措施的累积影响不仅限于直接成本，还波及筹资策略、库存管理和地理采购决策。供应商和终端用户正在积极应对，透过重新评估供应商所在地、探索替代供应商以及加快本地可用材料的认证，来规避单一来源采购的风险。

详细的細項分析揭示了表达系统、服务类型、蛋白质类别、应用程式和最终用户如何以独特的方式影响产能需求和策略重点。

对市场区隔的深入理解揭示了不同表达系统、服务形式、蛋白质类别、应用领域和最终用户的需求驱动因素和产能要求。表达系统选项包括细菌平台（包括革兰氏阴性菌和革兰氏阳性菌，它们会影响溶解度和转译后修饰策略）；基于大肠桿菌和小麦胚芽的无细胞形式，可实现快速原型製作；适用于复杂折迭和糖基化的昆虫和哺乳动物系统；以植物细胞培养为中心的植物方法；强调畜牧性表达的基因转殖基因动物平台以及兼顾基因动物平台；

区域趋势和能力丛集将影响创新、製造深度和法规环境如何驱动全球市场的采购和伙伴关係策略。

区域趋势将在决定创新、产能扩张和服务专业化融合的格局方面发挥关键作用。美洲拥有密集且成熟的学术机构、生物技术公司和药物研发生态系统，推动了对先进细胞株开发、高性能自动化平台和大规模生产服务的需求。这种环境促进了合约服务提供者与企业内部团队之间的伙伴关係，支援快速商业化管道，并着重于监管合规和供应链整合。

主要企业的蛋白质表现服务供应商部署的竞争策略和营运差异化措施，旨在整合自动化、扩展服务组合併确保供应链可靠性。

蛋白质表现和生产生态系统中的主要企业正专注于一系列策略要务，这些要务强调平台广度、品质系统和服务整合。市场领导正在投资模组化自动化，以连接发现和生产阶段，从而促进技术转移并缩短从概念到规模化的週期。许多供应商也正在扩展其服务组合，纳入细胞株开发、标记和标记服务以及下游纯化等互补能力，以在客户工作流程中创造更高价值，并减少各阶段之间的交接摩擦。

结合自动化、供应链多元化、整合服务和合规监管等切实可行的策略措施，以建立可持续的竞争优势。

产业领导者应优先考虑整合科研能力、商业性韧性和以客户为中心的服务交付的实际措施。首先，加快自动化平台的合格和集成，以减少人工操作造成的变异性并缩短实验週期。高效能筛检结合机器人纯化技术，可在保持可重复性的同时显着提高通量。其次，透过供应商多元化和製定区域筹资策略来降低关税和物流风险。这包括对替代试剂来源合格，并探索关键耗材的本地生产伙伴关係。

调查方法结合了第一手访谈、二手证据筛选和严格的三角验证，以得出检验的技术和商业性见解。

本分析结合了第一手和第二手研究方法，以确保得出可靠且检验的结论。第一手研究包括对学术机构、生物技术负责人、合约研究组织 (CRO)、诊断实验室和製药公司的研发、采购和技术总监进行结构化访谈，并辅以与涵盖表达系统和服务类型的服务供应商的深入讨论。从这些对话中获得的见解为营运重点、挑战和策略意图的定性评估提供了依据，并结合了可观察到的行业趋势进行验证。

透过综合分析技术成熟度、商业性整合和供应链韧性，为蛋白质表现和生产相关人员确定策略重点。

总之，蛋白质表现和生产服务环境的特征是技术快速进步、商业模式不断演进以及对供应链韧性的日益重视。从细菌和无细胞表达系统到先进的哺乳动物和植物表达平台，表达系统的多样性使得技术相容性和营运灵活性成为决定策略契合度的关键因素。能够成功整合自动化技术、拓展服务范围并展现监管合规能力的服务供应商，将更有能力为包括学术机构、生物技术创新者、合约研究组织 (CRO)、诊断实验室和製药公司在内的各类终端用户提供最佳服务。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 市场进入策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章 美国关税的累积影响，2025年

第七章 人工智慧的累积影响，2025年

8. 按表达系统分類的蛋白质表现及生产服务市场

  • 细菌
    • 革兰氏阴性菌
    • 革兰氏阳性菌
  • 无细胞
    • 大肠桿菌
    • 小麦胚芽
  • 昆虫
  • 哺乳动物
  • 植物性
  • 基因改造动物
  • 酵母菌

9. 按蛋白质类型分類的蛋白质表现与生产服务市场

  • 融合蛋白
    • 商品及服务税标籤
    • 组胺酸标籤
  • 单株抗体
  • 天然蛋白质
  • 重组蛋白
  • 合成蛋白质

第十章：按应用分類的蛋白质表现与生产服务市场

  • 诊断
  • 工业酵素
  • 个人化医疗
  • 研究
  • 治疗研发

第十一章：按最终用户分類的蛋白质表现与生产服务市场

  • 学术机构
  • 生技公司
  • 受託研究机构
  • 诊断实验室
  • 製药公司

12. 各地区蛋白质表现及生产服务市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章：依组别分類的蛋白质表现与生产服务市场

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

14. 各国蛋白质表现与生产服务市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

16. 美国蛋白质表现与生产服务市场

第十七章：中国蛋白质表现与生产服务市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Agilent Technologies, Inc.
  • Ajinomoto Bio-Pharma Services
  • Aldevron, LLC
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • Charles River Laboratories International, Inc.
  • Creative Biolabs, Inc.
  • Domainex Limited
  • GenScript BIoTech Corporation
  • Iksuda Therapeutics, Inc.
  • Lonza Group AG
  • Merck KGaA
  • Promega Corporation
  • QIAGEN NV
  • Sino Biological, Inc.
  • Sygnature Discovery Ltd.
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
  • VectorBuilder Inc.
  • WuXi Biologics Inc.
Product Code: MRR-7A380DA7C462

The Protein Expression & Production Service Market was valued at USD 854.60 million in 2025 and is projected to grow to USD 934.22 million in 2026, with a CAGR of 10.11%, reaching USD 1,678.04 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 854.60 million
Estimated Year [2026] USD 934.22 million
Forecast Year [2032] USD 1,678.04 million
CAGR (%) 10.11%

A strategic orientation that frames protein expression and production services as pivotal enablers of translational science, commercial biologics, and diagnostic innovation

The protein expression and production landscape occupies a central role across therapeutic development, diagnostic advancement, and industrial biotechnology innovation. This report opens with a focused orientation that positions protein expression capabilities as foundational to modern life sciences workflows, from exploratory research to scalable manufacturing. It emphasizes how technical choices-such as the selection of expression systems and the degree of platform automation-influence downstream timelines, reproducibility, and regulatory readiness.

Readers will find a synthesis of operational drivers, technological inflection points, and stakeholder priorities that collectively define strategic decision frameworks. The introduction highlights the interplay between scientific objectives and commercial constraints, noting how R&D teams, contract service providers, and in-house biologics manufacturers prioritize throughput, fidelity, and cost-efficiency differently. This framing sets the stage for deeper analysis of segmentation, regional dynamics, and policy-driven disruptions.

By anchoring the conversation in operational realities and translational goals, the introduction outlines the report's approach to evaluating capabilities, service models, and adoption vectors. It explains how subsequent sections connect laboratory practice with commercial strategy, enabling leaders to assess where investment in expression platforms, automation, or supply chain adjustments will deliver measurable value.

Converging technological and operational inflections that are accelerating throughput, modular service models, and quality-driven integration across expression platforms

The protein expression and production sector is undergoing a set of transformative shifts that are remapping competitive advantage across technical, operational, and commercial dimensions. Advances in cell-free systems and refinements in mammalian and yeast platforms are pushing reproducibility and speed gains, while increased adoption of automation platforms is compressing experimental cycles and elevating throughput. Moreover, integration of high-throughput screening with robotic purification has changed the calculus for outsourcing versus in-house capability development, enabling organizations to scale discovery workflows with fewer manual interventions.

Concurrently, there is growing convergence between synthetic biology approaches and platform engineering, prompting providers to expand services beyond conventional recombinant protein production into areas such as fusion protein engineering and peptidomimetic synthesis. These trends have been accompanied by an intensifying focus on quality attributes that support regulatory pathways and therapeutic translation, driving closer alignment between production processes and downstream analytical validation practices. In addition, commercial pressures-rising demand for personalized medicine inputs and a surge in biologics R&D-are incentivizing modular service models that combine cell line development, custom expression services, and bulk production as integrated offerings.

Taken together, these inflections are reshaping value propositions for service providers, elevating partnerships that can deliver end-to-end workflows, and redefining procurement criteria for academic, biotech, CRO, diagnostic, and pharmaceutical end users.

Comprehensive assessment of how 2025 tariff actions reshaped procurement, supply chain resilience, and sourcing strategies for protein expression and production services

Tariff policy changes and trade actions enacted in 2025 have introduced a new set of considerations for organizations that depend on global supply chains for reagents, consumables, and specialized instrumentation tied to protein expression and production. The cumulative impact of these measures extends beyond direct cost implications to affect procurement strategies, inventory management, and geographic sourcing decisions. Providers and end users have responded by reassessing supplier footprints, seeking alternative vendors, and accelerating qualification of regionally available materials to avoid single-source vulnerabilities.

Logistical friction has also increased lead-time uncertainty for imported components, prompting organizations to enlarge safety stocks for critical reagents and reevaluate just-in-time procurement models. This shift has raised working capital requirements and influenced the timing of large capital equipment purchases, with some organizations preferring local manufacturing or closer regional partnerships to mitigate tariff exposure. Regulatory compliance pathways have become more complex when tariff-driven re-routing affects customs documentation and origin declarations, making coordinated cross-functional engagement between procurement, quality assurance, and regulatory teams essential.

In response, contract providers have adapted commercial terms, introduced tariff-pass-through clauses in service agreements, and in some cases localized downstream services to preserve competitiveness. The broader implication is an acceleration of strategic nearshoring and supplier diversification, where resilience and supply certainty are increasingly prioritized alongside traditional performance metrics like yield and purity.

Deep segmentation analysis revealing how expression systems, service types, protein classes, applications, and end users uniquely shape capability demands and strategic priorities

A nuanced understanding of market segmentation reveals distinct demand drivers and capability requirements across expression systems, service types, protein classes, applications, and end users. Expression system choices include bacterial platforms, with Gram-negative and Gram-positive subdivisions that influence solubility and post-translational modification strategies; cell-free formats including E. coli-based and wheat germ-based systems that offer rapid prototyping; insect and mammalian systems that are favored for complex folding and glycosylation; plant-based approaches centered on plant cell cultures; transgenic animal routes that emphasize livestock expression; and yeast platforms that balance scalability with eukaryotic processing.

Service-type segmentation spans automated platforms that combine high-throughput screening with robotic purification capabilities, bulk production services optimized for larger batch runs, cell line development workflows that secure long-term production stability, and custom protein expression offerings that often include labeling services and tagged protein delivery to meet specific experimental needs. Protein-type distinctions matter operationally: fusion proteins, with common variants such as GST-tagged and His-tagged constructs, are designed for ease of purification and functional studies; monoclonal antibodies demand rigorous process control for therapeutic applications; native and recombinant proteins serve diverse research and diagnostic purposes; and synthetic proteins, including peptidomimetics, are increasingly important for targeted modalities.

Application-oriented segmentation encompasses diagnostics, industrial enzymes, personalized medicine, research, and therapeutic development, each with unique regulatory and scalability requirements. End users range from academic institutions that prioritize flexibility and cost-effectiveness, to biotechnology companies and pharmaceutical firms focused on translational throughput and compliance, to contract research organizations and diagnostic labs that require robust quality systems and reproducible delivery. Understanding how these segments intersect clarifies where investments in automation, platform diversity, or specialized services will yield the greatest strategic return.

Regional dynamics and capability clusters that determine how innovation, manufacturing depth, and regulatory environments drive sourcing and partnership strategies across global markets

Regional dynamics play a decisive role in shaping where innovation, capacity expansion, and service specialization coalesce. The Americas present a mature ecosystem with a dense concentration of academic institutions, biotechnology companies, and pharmaceutical developers, driving demand for advanced cell line development, high-throughput automated platforms, and large-scale production services. This environment encourages partnerships between contract providers and in-house teams, and supports rapid commercialization pathways that emphasize regulatory readiness and supply chain integration.

Europe, Middle East & Africa display a heterogeneous landscape where pockets of scientific excellence coexist with regions focused on cost-efficient manufacturing and localized diagnostic needs. Here, regulatory frameworks and public procurement priorities influence service design, incentivizing providers to offer flexible customization and compliance-oriented workflows. Cross-border collaboration within the region has facilitated shared infrastructure approaches that reduce barriers for smaller biotech ventures while enabling larger firms to leverage regional specialty capabilities.

Asia-Pacific continues to expand both capacity and technical sophistication, with growing investment in mammalian systems, yeast-based production, and localized reagent manufacturing. Industrial-scale enzyme production and contract manufacturing services are particularly prominent, and the region's manufacturing depth supports shorter lead times for equipment and consumables. Across all regions, strategic considerations such as tariff exposure, talent availability, and the maturity of local regulatory pathways inform decisions about where to locate critical capabilities and which partnerships to prioritize.

Competitive strategies and operational differentiators that leading firms deploy to integrate automation, broaden service portfolios, and secure supply chain reliability in protein expression services

Leading companies in the protein expression and production ecosystem are converging around a set of strategic imperatives that emphasize platform breadth, quality systems, and service integration. Market leaders are investing in modular automation that bridges discovery and production phases, enabling smoother technology transfer and reducing cycle times from concept to scale. Many providers are also expanding service portfolios to include complementary capabilities-such as cell line development, labeling and tag services, and downstream purification-to capture higher value across client workflows and reduce friction during handoffs between stages.

Strategic partnerships and co-development agreements have become common as firms seek to combine specialized technical know-how with broader commercial reach. Firms that prioritize traceable quality systems and robust documentation practices position themselves favorably for therapeutics and diagnostics clients with stringent regulatory expectations. Additionally, firms that offer flexible commercial models, including project-based scopes, subscription access to data portals, and tiered service levels, are better able to serve diverse end users from academic researchers to large pharmaceutical companies.

Operationally, investments in supply chain transparency, vendor qualification, and regional service hubs are differentiators in an environment where sourcing certainty matters. Companies that align technical capabilities with responsive customer engagement models-offering consultative design, rapid prototyping, and scale-up support-are increasingly perceived as strategic partners rather than transactional vendors.

Practical strategic actions leaders should implement to combine automation, supply diversification, integrated services, and regulatory readiness for durable competitive advantage

Industry leaders should prioritize a set of actionable initiatives that align scientific capability with commercial resilience and customer-centric delivery. First, accelerate qualification and integration of automated platforms to reduce manual variability and shorten experimental cycles; pairing high-throughput screening with robotic purification will materially improve throughput while maintaining reproducibility. Second, diversify supplier bases and develop regional sourcing strategies to mitigate tariff and logistics risks, including qualification of alternative reagent sources and exploring local manufacturing partnerships for critical consumables.

Third, broaden service offerings to provide end-to-end solutions that combine cell line development, custom expression options with labeling and tagged protein services, and scalable bulk production. This integrated approach increases customer retention and simplifies project management across client organizations. Fourth, strengthen quality management systems and regulatory readiness to better support therapeutic and diagnostic customers; invest in documentation, validation pathways, and personnel training to meet evolving compliance expectations. Fifth, engage in targeted collaborations with academic centers, biotech innovators, and CROs to co-develop specialized products such as fusion proteins, monoclonal antibody workflows, and peptidomimetic synthesis capabilities that address emerging application needs.

Finally, implement flexible commercial arrangements-including tiered pricing, subscription models, and bespoke data-services-that align value creation with client budgets and timelines. These steps, taken in combination, will reinforce competitive positioning and support sustainable growth in a rapidly evolving landscape.

Methodological framework combining primary interviews, secondary evidence triage, and rigorous triangulation to produce validated insights across technical and commercial dimensions

This analysis synthesizes primary and secondary research methodologies to ensure robust, verifiable insights. Primary inputs included structured interviews with R&D leaders, procurement officers, and technical heads across academic institutions, biotech firms, CROs, diagnostic labs, and pharmaceutical companies, supplemented by in-depth discussions with service providers across expression systems and service types. These conversations informed qualitative assessments of operational priorities, pain points, and strategic intent, and were triangulated with observable industry behavior.

Secondary research encompassed rigorous review of peer-reviewed publications, regulatory guidance, patent filings, and company disclosures that pertain to expression technologies, automation adoption, and supply chain practices. The research team applied cross-validation techniques to reconcile interview findings with documented evidence, emphasizing reproducibility and methodological transparency. Segmentation was defined to reflect actionable distinctions: expression systems (including bacterial, cell-free, insect, mammalian, plant-based, transgenic animal, and yeast), service types (from automated platforms to custom protein expression), protein types (including fusion constructs and synthetic peptides), applications, and end-user categories.

Analytical steps involved process mapping, capability gap analysis, and thematic synthesis to identify recurring patterns and strategic inflection points. Limitations and potential biases were addressed through respondent diversity and iterative validation rounds, ensuring conclusions reflect a balanced and contemporary view of the protein expression and production services landscape.

A synthesis that connects technological maturity, commercial integration, and supply resilience to define strategic priorities for protein expression and production stakeholders

In conclusion, the protein expression and production services environment is defined by accelerating technological refinement, evolving commercial models, and heightened attention to supply chain resilience. Expression system diversity-from bacterial and cell-free approaches through advanced mammalian and plant-based platforms-creates a landscape where technical fit and operational agility determine strategic suitability. Service providers that successfully integrate automation, broaden their service portfolios, and demonstrate regulatory readiness will be best positioned to serve the wide spectrum of end users, including academic institutions, biotech innovators, CROs, diagnostic labs, and pharmaceutical companies.

Tax and trade policy shifts, including tariff actions in 2025, have underscored the importance of supplier diversification and regional capacity planning, making procurement strategy a core component of competitive differentiation. Looking forward, the most successful organizations will be those that align scientific excellence with resilient commercial architectures-investing in modular automation, platform interoperability, and customer-centric service design. Collectively, these elements will support more predictable translation from discovery to application and strengthen the role of protein expression services as enablers of therapeutic, diagnostic, and industrial innovation.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Protein Expression & Production Service Market, by Expression System

  • 8.1. Bacteria
    • 8.1.1. Gram Negative
    • 8.1.2. Gram Positive
  • 8.2. Cell Free
    • 8.2.1. E Coli Based
    • 8.2.2. Wheat Germ Based
  • 8.3. Insect
  • 8.4. Mammalian
  • 8.5. Plant Based
  • 8.6. Transgenic Animal
  • 8.7. Yeast

9. Protein Expression & Production Service Market, by Protein Type

  • 9.1. Fusion Protein
    • 9.1.1. GST Tagged
    • 9.1.2. His Tagged
  • 9.2. Monoclonal Antibody
  • 9.3. Native Protein
  • 9.4. Recombinant Protein
  • 9.5. Synthetic Protein

10. Protein Expression & Production Service Market, by Application

  • 10.1. Diagnostics
  • 10.2. Industrial Enzymes
  • 10.3. Personalized Medicine
  • 10.4. Research
  • 10.5. Therapeutic Development

11. Protein Expression & Production Service Market, by End User

  • 11.1. Academic Institutions
  • 11.2. Biotechnology Companies
  • 11.3. Contract Research Organizations
  • 11.4. Diagnostic Labs
  • 11.5. Pharmaceutical Companies

12. Protein Expression & Production Service Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Protein Expression & Production Service Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Protein Expression & Production Service Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Protein Expression & Production Service Market

16. China Protein Expression & Production Service Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Agilent Technologies, Inc.
  • 17.6. Ajinomoto Bio-Pharma Services
  • 17.7. Aldevron, LLC
  • 17.8. Bio-Rad Laboratories, Inc.
  • 17.9. Bio-Techne Corporation
  • 17.10. Charles River Laboratories International, Inc.
  • 17.11. Creative Biolabs, Inc.
  • 17.12. Domainex Limited
  • 17.13. GenScript Biotech Corporation
  • 17.14. Iksuda Therapeutics, Inc.
  • 17.15. Lonza Group AG
  • 17.16. Merck KGaA
  • 17.17. Promega Corporation
  • 17.18. QIAGEN N.V.
  • 17.19. Sino Biological, Inc.
  • 17.20. Sygnature Discovery Ltd.
  • 17.21. Takara Bio Inc.
  • 17.22. Thermo Fisher Scientific Inc.
  • 17.23. VectorBuilder Inc.
  • 17.24. WuXi Biologics Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY EXPRESSION SYSTEM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY PROTEIN TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY EXPRESSION SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY BACTERIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY BACTERIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY BACTERIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY BACTERIA, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY GRAM NEGATIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY GRAM NEGATIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY GRAM NEGATIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY GRAM POSITIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY GRAM POSITIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY GRAM POSITIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY CELL FREE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY CELL FREE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY CELL FREE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY CELL FREE, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY E COLI BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY E COLI BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY E COLI BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY WHEAT GERM BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY WHEAT GERM BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY WHEAT GERM BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY INSECT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY INSECT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY INSECT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY MAMMALIAN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY MAMMALIAN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY MAMMALIAN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY PLANT BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY PLANT BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY PLANT BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY TRANSGENIC ANIMAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY TRANSGENIC ANIMAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY TRANSGENIC ANIMAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY YEAST, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY YEAST, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY YEAST, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY PROTEIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY FUSION PROTEIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY FUSION PROTEIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY FUSION PROTEIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY FUSION PROTEIN, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY GST TAGGED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY GST TAGGED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY GST TAGGED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY HIS TAGGED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY HIS TAGGED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY HIS TAGGED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY MONOCLONAL ANTIBODY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY MONOCLONAL ANTIBODY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY MONOCLONAL ANTIBODY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY NATIVE PROTEIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY NATIVE PROTEIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY NATIVE PROTEIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY RECOMBINANT PROTEIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY RECOMBINANT PROTEIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY RECOMBINANT PROTEIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY SYNTHETIC PROTEIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY SYNTHETIC PROTEIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY SYNTHETIC PROTEIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY INDUSTRIAL ENZYMES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY INDUSTRIAL ENZYMES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY INDUSTRIAL ENZYMES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY PERSONALIZED MEDICINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY PERSONALIZED MEDICINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY THERAPEUTIC DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY THERAPEUTIC DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY THERAPEUTIC DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY DIAGNOSTIC LABS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY DIAGNOSTIC LABS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY DIAGNOSTIC LABS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY EXPRESSION SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY BACTERIA, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY CELL FREE, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY PROTEIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY FUSION PROTEIN, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY EXPRESSION SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY BACTERIA, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY CELL FREE, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY PROTEIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY FUSION PROTEIN, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY EXPRESSION SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 112. LATIN AMERICA PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY BACTERIA, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY CELL FREE, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY PROTEIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY FUSION PROTEIN, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY EXPRESSION SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY BACTERIA, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY CELL FREE, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY PROTEIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY FUSION PROTEIN, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY EXPRESSION SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY BACTERIA, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY CELL FREE, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY PROTEIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY FUSION PROTEIN, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. MIDDLE EAST PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. MIDDLE EAST PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY EXPRESSION SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 136. MIDDLE EAST PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY BACTERIA, 2018-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY CELL FREE, 2018-2032 (USD MILLION)
  • TABLE 138. MIDDLE EAST PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY PROTEIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY FUSION PROTEIN, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 142. AFRICA PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 143. AFRICA PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY EXPRESSION SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 144. AFRICA PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY BACTERIA, 2018-2032 (USD MILLION)
  • TABLE 145. AFRICA PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY CELL FREE, 2018-2032 (USD MILLION)
  • TABLE 146. AFRICA PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY PROTEIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. AFRICA PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY FUSION PROTEIN, 2018-2032 (USD MILLION)
  • TABLE 148. AFRICA PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 149. AFRICA PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY EXPRESSION SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY BACTERIA, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY CELL FREE, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY PROTEIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY FUSION PROTEIN, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 159. ASEAN PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. ASEAN PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY EXPRESSION SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 161. ASEAN PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY BACTERIA, 2018-2032 (USD MILLION)
  • TABLE 162. ASEAN PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY CELL FREE, 2018-2032 (USD MILLION)
  • TABLE 163. ASEAN PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY PROTEIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. ASEAN PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY FUSION PROTEIN, 2018-2032 (USD MILLION)
  • TABLE 165. ASEAN PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 166. ASEAN PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 167. GCC PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. GCC PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY EXPRESSION SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 169. GCC PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY BACTERIA, 2018-2032 (USD MILLION)
  • TABLE 170. GCC PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY CELL FREE, 2018-2032 (USD MILLION)
  • TABLE 171. GCC PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY PROTEIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. GCC PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY FUSION PROTEIN, 2018-2032 (USD MILLION)
  • TABLE 173. GCC PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 174. GCC PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPEAN UNION PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPEAN UNION PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY EXPRESSION SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPEAN UNION PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY BACTERIA, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPEAN UNION PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY CELL FREE, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPEAN UNION PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY PROTEIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPEAN UNION PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY FUSION PROTEIN, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPEAN UNION PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPEAN UNION PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 183. BRICS PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. BRICS PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY EXPRESSION SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 185. BRICS PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY BACTERIA, 2018-2032 (USD MILLION)
  • TABLE 186. BRICS PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY CELL FREE, 2018-2032 (USD MILLION)
  • TABLE 187. BRICS PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY PROTEIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. BRICS PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY FUSION PROTEIN, 2018-2032 (USD MILLION)
  • TABLE 189. BRICS PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 190. BRICS PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 191. G7 PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 192. G7 PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY EXPRESSION SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 193. G7 PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY BACTERIA, 2018-2032 (USD MILLION)
  • TABLE 194. G7 PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY CELL FREE, 2018-2032 (USD MILLION)
  • TABLE 195. G7 PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY PROTEIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. G7 PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY FUSION PROTEIN, 2018-2032 (USD MILLION)
  • TABLE 197. G7 PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 198. G7 PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 199. NATO PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 200. NATO PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY EXPRESSION SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 201. NATO PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY BACTERIA, 2018-2032 (USD MILLION)
  • TABLE 202. NATO PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY CELL FREE, 2018-2032 (USD MILLION)
  • TABLE 203. NATO PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY PROTEIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. NATO PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY FUSION PROTEIN, 2018-2032 (USD MILLION)
  • TABLE 205. NATO PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 206. NATO PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 207. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. UNITED STATES PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 209. UNITED STATES PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY EXPRESSION SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 210. UNITED STATES PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY BACTERIA, 2018-2032 (USD MILLION)
  • TABLE 211. UNITED STATES PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY CELL FREE, 2018-2032 (USD MILLION)
  • TABLE 212. UNITED STATES PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY PROTEIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. UNITED STATES PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY FUSION PROTEIN, 2018-2032 (USD MILLION)
  • TABLE 214. UNITED STATES PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 215. UNITED STATES PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 216. CHINA PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 217. CHINA PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY EXPRESSION SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 218. CHINA PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY BACTERIA, 2018-2032 (USD MILLION)
  • TABLE 219. CHINA PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY CELL FREE, 2018-2032 (USD MILLION)
  • TABLE 220. CHINA PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY PROTEIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 221. CHINA PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY FUSION PROTEIN, 2018-2032 (USD MILLION)
  • TABLE 222. CHINA PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 223. CHINA PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)